Advertisement.
Advertisement.
Advertisement.
| Market Cap | $196.38M |
| Volume | 614,759.00 |
| 52-Wk High | $1.61 |
| 52-Wk Low | $0.8372 |
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Lineage Cell Therapeutics Inc market cap is $196.38M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Lineage Cell Therapeutics Inc 52 week high is $1.61 as of July 26, 2024.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Lineage Cell Therapeutics Inc 52 week low is $0.8372 as of July 26, 2024.
Lineage Cell Therapeutics Inc stock price today is $1.02.
Lineage Cell Therapeutics Inc stock price yesterday was $1.04.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Lineage Cell Therapeutics Inc’s P/E ratio is -7.72.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Lineage Cell Therapeutics Inc P/B ratio is 2.7113.
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Lineage Cell Therapeutics Inc's EBITDA is -9.52.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Lineage Cell Therapeutics Inc 50-day moving average is $0.9828.
Lineage Cell Therapeutics Inc has 75 employees.